
Vivek Srinivasan
Vivek J. Srinivasan, PhD, is Associate Professor of Ophthalmology and Radiology at NYU Grossman School of Medicine, where he develops visible-light optical coherence tomography (OCT) for retinal and brain imaging.
1
APPEARANCES
1
PODCASTS
012
DEC 30
JAN 6
JAN 13
JAN 20
JAN 27
FEB 3
FEB 10
FEB 17
FEB 24
MAR 3
MAR 10
MAR 17
MAR 24
MAR 31
APR 7
APR 14
APR 21
APR 28
MAY 5
MAY 12
MAY 19
MAY 26
JUN 2
JUN 9
JUN 16
JUN 23
JUN 30
JUL 7
JUL 14
JUL 21
JUL 28
AUG 4
AUG 11
AUG 18
AUG 25
SEP 1
SEP 8
SEP 15
SEP 22
SEP 29
OCT 6
OCT 13
OCT 20
OCT 27
NOV 3
NOV 10
NOV 17
NOV 24
DEC 1
DEC 8
DEC 15
DEC 22
DEC 29
JAN 5
JAN 12
JAN 19
JAN 26
FEB 2
FEB 9
FEB 16
FEB 23
MAR 2
MAR 9
MAR 16
MAR 23
MAR 30
APR 6
APR 13
APR 20
APR 27
MAY 4
MAY 11
MAY 18
MAY 25
JUN 1
JUN 8
JUN 15
JUN 22
JUN 29
JUL 6
JUL 13
JUL 20
JUL 27
AUG 3
AUG 10
AUG 17
AUG 24
AUG 31
SEP 7
SEP 14
SEP 21
SEP 28
Sep 24, 2026
Lacquer Crack Visible Light OCT
6:23
6:36
6:52
6:58
15:56

Edmund ChoiHOST
We'd love to hear more about what is visible light OCT and what unique information can it provide to us that standard structural, spectral domain, or swept source OCT cannot.

Vivek SrinivasanGUEST
So the OCT that clinicians are familiar with uses near-infrared light, and that's nominally light beyond the visible spectrum, 700 nanometers or above.

Vivek SrinivasanGUEST
The visible light OCT uses wavelengths within the visible spectrum itself, so from 400 to 700 nanometers.

Vivek SrinivasanGUEST
And in this particular instance, from about 500 nanometers to 650 nanometers is what we used to image for this case.
9 MINS LATER

Edmund ChoiHOST
Is this something that may play a role in routine clinical practice? Or is it more going to be on the research side for us to understand more of the pathophysiology and how we can track patients longitudinally to really understand what happens in certain disease states? What do you see happening?